BIOCONNSEBiocon Limited· PharmaceuticalsMediumNeutral
Announced Wed, 4 Jun · 22:05 IST

Biocon Limited has informed the Exchange about Shareholders meeting

Board & Shareholder Meetings View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has announced the results of its postal ballot conducted via remote e-voting, with the last date of voting being June 4, 2025. Two resolutions were put to shareholders: (1) an Ordinary Resolution to increase the Authorised Share Capital and amend the Memorandum of Association, and (2) a Special Resolution to raise funds through the issuance of equity shares and/or other securities in one or more tranches. Both resolutions were approved with overwhelming majority — 99.999% in favour for the share capital increase (9,808 votes against out of 97.77 crore valid votes) and 99.499% in favour for the fund-raising resolution (48.88 lakh votes against). About 81.44% of total paid-up equity capital participated in the voting. Promoters and promoter group voted entirely in favour of both resolutions, and the Scrutinizer confirmed the results are valid.

Likely market impact

Shareholders have greenlit Biocon's plan to raise fresh capital and expand its authorised share capital, giving the company flexibility to issue new equity or convertible securities. This could lead to potential dilution but also signals the company's intent to fund growth initiatives. No negative surprise here — both resolutions passed with near-unanimous support.